Confidence in Concept CMVM University of Edinburgh Edinburgh Partners in Translation (EPiT)

Lead Research Organisation: University of Edinburgh

Abstract

Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.

Technical Summary

The Confidence in Concept scheme is a key part of MRC’s translational research strategy and provides annual awards to institutions, to be used flexibly to support the earliest stages of multiple translational research projects. The award can be used by the institution to support a number of preliminary-stage translational projects. The projects supported should aim to provide sufficient preliminary data to establish the viability of an approach –– before seeking more substantive funding.  It is intended to accelerate the transition from discovery research to translational development projects by supporting preliminary work or feasibility studies to establish the viability of an approach.

Publications

10 25 50
 
Description Appointment to MTAC - Ultrasound Needle Guidance CIC3
Geographic Reach National 
Policy Influence Type Participation in a advisory committee
 
Description Academy of Medical Sciences Clinical Starter - CRISPR CIC3
Amount £29,922 (GBP)
Organisation Academy of Medical Sciences (AMS) 
Sector Charity/Non Profit
Country United Kingdom
Start  
 
Description Axis Shield funding (miRNA sensors CIC3)
Amount £50,000 (GBP)
Organisation Axis-Shield 
Sector Private
Country United Kingdom
Start  
 
Description BK Medical - Super resolution ultrasound CIC3
Amount £590,000 (GBP)
Organisation BK Medical 
Sector Private
Country Denmark
Start  
 
Description CiC 2014 (Microvascular bed imaging)
Amount £274,000 (GBP)
Funding ID ST/M007804/1 
Organisation Science and Technologies Facilities Council (STFC) 
Sector Public
Country United Kingdom
Start 06/2016 
End 08/2018
 
Description CiC 2014 (Point of care miRNA)
Amount £100,000 (GBP)
Organisation Axis-Shield 
Sector Private
Country United Kingdom
Start 10/2017 
End 10/2020
 
Description CiC 2014 (cryopreservation hESC)
Amount £60,000 (GBP)
Organisation Cure Parkinson's Trust 
Sector Charity/Non Profit
Country United Kingdom
Start 05/2016 
End 05/2017
 
Description CiC 2014 (magnetosome)
Amount £120,000 (GBP)
Organisation National Research Council of Republic Indonesia (DRN) 
Sector Public
Country Indonesia
Start 10/2016 
End 10/2019
 
Description CiC 2014 (microvascular bed imaging)
Amount £914,000 (GBP)
Funding ID EP/N015320/1 
Organisation Engineering and Physical Sciences Research Council (EPSRC) 
Sector Public
Country United Kingdom
Start 02/2016 
End 01/2019
 
Description CiC 2014 (ultrasound guidance)
Amount £33,000 (GBP)
Organisation Edinburgh & Lothians Health Foundation 
Sector Charity/Non Profit
Country United Kingdom
Start 05/2016 
End 02/2017
 
Description CiC 2014 Tablet application for AD
Amount £1,350,000 (GBP)
Funding ID ES/N010728/1 
Organisation Economic and Social Research Council 
Sector Public
Country United Kingdom
Start 03/2016 
End 03/2020
 
Description CiC2014 (cryopreserved hESC)
Amount £464,030 (GBP)
Organisation UCB Pharma 
Sector Private
Country United Kingdom
Start 03/2016 
End 03/2020
 
Description CiliaCircuits: Molecular Principles Of Mammalian Axonemal Dynein Assembly
Amount € 2,000,000 (EUR)
Organisation European Commission H2020 
Sector Public
Country Belgium
Start 04/2020 
End 03/2025
 
Description Cure Parkinson's Trust - hESC CiC3
Amount £62,529 (GBP)
Organisation Cure Parkinson's Trust 
Sector Charity/Non Profit
Country United Kingdom
Start 05/2018 
End 04/2019
 
Description EPSRC Platform grant - Ultrasound in a needle CiC3
Amount £1,302,969 (GBP)
Funding ID EP/P027415/1 
Organisation Engineering and Physical Sciences Research Council (EPSRC) 
Sector Public
Country United Kingdom
Start 10/2017 
End 09/2022
 
Description European Lead Factory - Anti bacterials targeting the glycolytic pathways CiC3
Amount € 400,000 (EUR)
Funding ID PP-267 Bacterial Phosphofructokinase as a target for gram positive and gram negative drugs 
Organisation European Lead Factory 
Sector Public
Country European Union (EU)
Start 10/2016 
End 12/2018
 
Description IBioIC Studentship - Microfluidics CiC3
Amount £83,000 (GBP)
Organisation IBioIC 
Sector Academic/University
Country United Kingdom
Start 10/2015 
End 09/2019
 
Description International Centre for Cancer Vaccine Science PhD - Anti baterial targeting glycolytic pathways CiC3
Amount £120,000 (GBP)
Organisation International Centre for Cancer Vaccine Science 
Sector Learned Society
Country Poland
Start 11/2017 
End 11/2021
 
Description MRC Quinquennial review - CRISPR CiC3
Amount £2,000,000 (GBP)
Organisation Medical Research Council (MRC) 
Sector Public
Country United Kingdom
Start 10/2017 
End 04/2019
 
Description PhD - Atopic Dermatitis CIC3
Amount £120,000 (GBP)
Organisation University of Edinburgh 
Sector Academic/University
Country United Kingdom
Start 05/2017 
End 04/2021
 
Description Royal Society of Edinburgh - Microfluidics CiC3
Amount £50,000 (GBP)
Organisation Royal Society of Edinburgh (RSE) 
Sector Charity/Non Profit
Country United Kingdom
Start  
 
Description SNBTS - Microfluids CIC3
Amount £3,750 (GBP)
Organisation NHS National Services Scotland (NSS) 
Department Scottish National Blood Transfusion Service
Sector Public
Country United Kingdom
Start 02/2016 
End 04/2016
 
Description SULSA (Anti bacterials CIC3)
Amount £10,000 (GBP)
Organisation Scottish Universities Life Sciences Alliance 
Sector Academic/University
Country United Kingdom
Start  
 
Description Sarcoma UK - Magnetic Hyperthermia Therapy CiC3
Amount £8,385 (GBP)
Organisation Sarcoma UK 
Sector Charity/Non Profit
Country United Kingdom
Start  
 
Description Seed Awards in Science
Amount £54,308 (GBP)
Organisation Wellcome Trust 
Sector Charity/Non Profit
Country United Kingdom
Start  
 
Description Selcia - Anti bacterials targeting the glycolytic pathway CIC3
Amount £100,000 (GBP)
Organisation Selcia 
Sector Private
Country United Kingdom
Start  
 
Description Wellcome Trust Grant - hESC CiC3
Amount £231,504 (GBP)
Organisation Wellcome Trust 
Sector Charity/Non Profit
Country United Kingdom
Start 09/2016 
End 08/2019
 
Description Wellcome Trust ISSF2 - CRISPR CiC3
Amount £27,842 (GBP)
Organisation Wellcome Trust 
Department Wellcome Trust Institutional Strategic Support Fund
Sector Charity/Non Profit
Country United Kingdom
Start  
 
Title Development of new bonding technology - Ultrasound needle guidance CiC3 
Description Development of a new bonding technology for the packaging of ultrasound transducer arrays at low temperature and low pressure. 
Type Of Material Technology assay or reagent 
Year Produced 2016 
Provided To Others? No  
Impact Continued work on the bonding technology to make sure that it is at a point where we can look at the epidural needle as a system and that can carry out animal models. 
 
Title miRNA sensors - Hydrogels 
Description The project developed the first ever morpholino-crosslinked hydrogels. We demonstrated selective swelling in these materials as oligonucleotide/miRNA sensors. We have also worked to optimise morpholino composites as chemiresistive sensors as a detection mechanism, a process that continues with PhD students. 
Type Of Material Technology assay or reagent 
Year Produced 2016 
Provided To Others? No  
Impact PhD students continue to use this process 
 
Description AFM Ltd (ultrasound needle guidance CIC3) 
Organisation AFM
Country United Kingdom 
Sector Private 
PI Contribution Academic input
Collaborator Contribution Construction of piezocomposite material
Impact tbc
Start Year 2016
 
Description Advent - Anti bacterials targeting glycolytic pathway CiC3 
Organisation Advent Life Science
Country United Kingdom 
Sector Private 
PI Contribution We are in discussion with Advent Life Sciences to discuss founding a company around the development of small molecule anti-cancer drugs targeting enzymes regulating glycolysis and gluconeogenesis. Hit compounds have been identified from an ELF screen on the bacterial target and could provide a starting point for the cancer project. Advent are enthusiastic about the possibility of linking the Hupp and Walkinshaw labs with the Drug Discovery Unit (Wyatt) at Dundee and three way discussions involving Steven Butcher from Advent have taken place.
Collaborator Contribution Expertise
Impact no outputs to date
Start Year 2017
 
Description CiC (ultra sound imaging) 
Organisation BK Medical
Country Denmark 
Sector Private 
PI Contribution providing potential technology
Collaborator Contribution providing equipment We will take the tools forward for clinical testing with BK Medical (Copenhagen, Denmark). Collaboration agreement has been signed. The capital investment of £590,000 includes: 1. Contribution towards a PHD studentship to support the image analysis for clinical trials in order to identify a candidate disease. 2. Utilise secured funds from ongoing clinical studies (£16M DNAFT 82-2012-4) to generate data for the student above. 3. Provide clinical equipment and support in our lab to enable commercialization of our new technology. 4. Take over the legal costs following our initial IP protection.
Impact Grants patents methods
Start Year 2016
 
Description CiC 2014 (anti-bacterial) 
Organisation Selcia
Country United Kingdom 
Sector Private 
PI Contribution structure based drug design
Collaborator Contribution medicinal chemistry
Impact As a result of our preliminary work on developing assays to test for small molecule inhibitors of the glycolytic pathway we have been awarded two grants to develop High Throughput Screens for testing by the European Lead Factory: project ref: "ADF15-0087" entitled: "bacterial PFK inhibition" and project ref: "ADF15-0089" entitled: "FBA as an antibacterial target " have both been accepted for screening by the ELF review panel.
Start Year 2015
 
Description CiC 2014 (crryopreserved hESC) 
Organisation University of Strathclyde
Country United Kingdom 
Sector Academic/University 
PI Contribution stem Cells
Collaborator Contribution Stabilisation technology
Impact Enhanced existing collaboration with Dr Michele Zagnoni (University of Strathclyde). On 29th February, we submitted a full proposal to the Wellcome Trust for a Biomedical Resource and Technology grant, which plans to use technology obtained during this MRC CiC project.
Start Year 2016
 
Description CiC 2014 (cryopreserved hESC) 
Organisation Cardiff University
Country United Kingdom 
Sector Academic/University 
PI Contribution New collaboration with Dr Mariah Lelos (Cardiff University). In December, 2015 we transported cryopreserved midbrain dopaminergic (mDA) precursors to Dr Lelos' lab for transplantation into immune-compromised rats.
Collaborator Contribution transplantation into immune-compromised rats
Impact This is a direct application of the know-how gained from this MRC CiC project.
Start Year 2015
 
Description CiC 2014 (point of care miRNA) 
Organisation Axis-Shield
Country United Kingdom 
Sector Private 
PI Contribution new technology
Collaborator Contribution testing requirement
Impact patent application and studentship
Start Year 2015
 
Description CiC 2014 (ultrasound guidance) 
Organisation University of Glasgow
Country United Kingdom 
Sector Academic/University 
PI Contribution medical concept and engineering
Collaborator Contribution multiple expertise in surgery and engineering
Impact The two applicants (Fiona Denison and Marc Desmulliez) did put together multi-lateral partnership with the following people: 1) Prof. Graeme Maccleod, from NHS Tayside and Ninewells Hospital. Graeme is an anaesthetist. 2) Prof. Alistair Milne, from NHS Lothian. Alistair is an anaesthetist. 3) Prof. Christine Demore, from the University of Glasgow. Christine is an expert in ultrasound arrays. Rachel MacPhillips, Christine's PhD student, spent about two weeks working with my staff on the bonding technology for the epidural needle. 4) Dr. Holly Lay, from the University of Glasgow. Holly is a Research Associate specialised in image processing of ultrasound images.
Start Year 2015
 
Description CiC 2014 (ultrasound guidance) 
Organisation University of Glasgow
Country United Kingdom 
Sector Academic/University 
PI Contribution medical concept and engineering
Collaborator Contribution multiple expertise in surgery and engineering
Impact The two applicants (Fiona Denison and Marc Desmulliez) did put together multi-lateral partnership with the following people: 1) Prof. Graeme Maccleod, from NHS Tayside and Ninewells Hospital. Graeme is an anaesthetist. 2) Prof. Alistair Milne, from NHS Lothian. Alistair is an anaesthetist. 3) Prof. Christine Demore, from the University of Glasgow. Christine is an expert in ultrasound arrays. Rachel MacPhillips, Christine's PhD student, spent about two weeks working with my staff on the bonding technology for the epidural needle. 4) Dr. Holly Lay, from the University of Glasgow. Holly is a Research Associate specialised in image processing of ultrasound images.
Start Year 2015
 
Description CiC2014 ((atopic dermatitis) 
Organisation LEO Pharma (including subsidiary Peplin Ltd)
Country Denmark 
Sector Private 
PI Contribution providing potential agents for atopic dermatitis
Collaborator Contribution screening on in-house systems
Impact data
Start Year 2015
 
Description CiC2014 ((atopic dermatitis) 
Organisation LEO Pharma (including subsidiary Peplin Ltd)
Country Denmark 
Sector Private 
PI Contribution providing potential agents for atopic dermatitis
Collaborator Contribution screening on in-house systems
Impact data
Start Year 2015
 
Description CiC2014 (tablet for AD diagnosis) 
Organisation NHS Scotland
Country United Kingdom 
Sector Public 
PI Contribution Tablet AD for detection
Collaborator Contribution To further increase the rate of recruitment of patients with mild Alzheimer's disease
Impact To further increase the rate of recruitment of patients with mild Alzheimer's disease we have then widened our recruitment area beyond Stirling to include two consultants at the Community Hospital in Falkirk: Drs Debbie Browne and Parvez Thekkumpurath have agreed to refer patients with mild Alzheimer's disease to our study. The study has also been added to the Join Dementia Research (JDR) register, which is a national register of over 14,000 patients and healthy individuals interested in taking part in dementia research. This service allows prospective participants, who meet eligibility criteria for a study, to express interest in taking part and provides researchers with the contact details of interested patients. This will increase the rate of recruitment for both the current study and future work.
Start Year 2015
 
Description Community Hospitals (AD device) 
Organisation Community Hospital Stirling
Country United Kingdom 
Sector Hospitals 
PI Contribution Commenced new collaboration with Community hospitals to increase recruitment to the study.
Collaborator Contribution For the purpose of this study the team have started a collaboration with the Community Hospital in Stirling. To further increase the rate of recruitment of patients with mild Alzheimer's disease they have then widened their recruitment area beyond Stirling to include two consultants at the Community Hospital in Falkirk who have agreed to refer patients with mild Alzheimer's disease to the study. The study has also been added to the Join Dementia Research (JDR) register, which is a national register of over 14,000 patients and healthy individuals interested in taking part in dementia research. This service allows prospective participants, who meet eligibility criteria for a study, to express interest in taking part and provides researchers with the contact details of interested patients. We will capitalize on these new links in our future work.
Impact Additional recruits to the study and the Dementia Research register
Start Year 2016
 
Description Dundee Drug Discovery Unit - Anti bacterials targeting the glycolytic pathway CiC3 
Organisation University of Dundee
Department Drug Discovery Unit
Country United Kingdom 
Sector Academic/University 
PI Contribution We are in discussion with Advent Life Sciences to discuss founding a company around the development of small molecule anti-cancer drugs targeting enzymes regulating glycolysis and gluconeogenesis. Hit compounds have been identified from an ELF screen on the bacterial target and could provide a starting point for the cancer project. Advent are enthusiastic about the possibility of linking the Hupp and Walkinshaw labs with the Drug Discovery Unit (Wyatt) at Dundee and three way discussions involving Steven Butcher from Advent have taken place.
Collaborator Contribution Expertise
Impact No output to date
Start Year 2017
 
Description ELF (anti bacterials CIC3) 
Organisation European Lead Factory
Country European Union (EU) 
Sector Public 
PI Contribution Discovery research
Collaborator Contribution PP-267 Bacterial phosphofructokinase as a target for gram positive and gram negative drugs (LYG2016-00087) 445,000 compounds were screened
Impact A Qualified Hit List of 26 compounds has been generated. Chemistry was developed on three hit families.
Start Year 2016
 
Description Identification of drugs for atopic dermatitis 
Organisation LEO Foundation
Country Denmark 
Sector Charity/Non Profit 
PI Contribution selection of agents
Collaborator Contribution research models
Impact new potential agents
Start Year 2016
 
Description Mitigating radiation induced lung injury 
Organisation Lamellar Biomedical Ltd
Country United Kingdom 
Sector Private 
PI Contribution Joint patent application PCT/GB2019/05112
Collaborator Contribution Joint patent application PCT/GB2019/05112
Impact No outputs to date.
Start Year 2018
 
Description Radiation induced damage CiC3 
Organisation Lamellar Biomedical Ltd
Country United Kingdom 
Sector Private 
PI Contribution model for radiation damage in sheep
Collaborator Contribution Lamellasomes as potential protectant
Impact positive data obtained
Start Year 2016
 
Description SNBTS - Microfluidics CiC3 
Organisation NHS National Services Scotland (NSS)
Department Scottish National Blood Transfusion Service
Country United Kingdom 
Sector Public 
PI Contribution Intellectual Property
Collaborator Contribution Service
Impact unknown
Start Year 2017
 
Description Sarcoma UK (Magnetic Hyperthermia Therapy CIC3) 
Organisation Sarcoma UK
Country United Kingdom 
Sector Charity/Non Profit 
PI Contribution Academic input
Collaborator Contribution Development of Magnetic Nanoparticle Bearing Mesenchymal Stem Cells for Magnetic Hyperthermia Treatment of Sarcomas
Impact tbc
Start Year 2016
 
Description St Andrew's University - Anti bacterials 
Organisation University of St Andrews
Country United Kingdom 
Sector Academic/University 
PI Contribution Project idea
Collaborator Contribution to test lead compounds in a potentially novel therapy against TB
Impact TBC
Start Year 2015
 
Description Sunray Scientific - Ultrasound needle CIC3 
Organisation SunRay Scientific LLC
Country United States 
Sector Private 
PI Contribution Intellectual Property
Collaborator Contribution Manufacturing of paste material - anisotropic conductive adhesives. In kind contributions: the provision of paste materials at a reduced price, the secondment of Mark Leonard to learn about the bonding technology in the USA, the provision of free expertise during regular teleconference calls with the company.
Impact Secondment of Dr David Watson, PDRA part of the project to Sunray Scientific for one week. Collaborations assisted the £1.3m EPSRC platform grant.
Start Year 2017
 
Description Super resolution ultrasound CiC3 
Organisation BK Medical
Country Denmark 
Sector Private 
PI Contribution we are providing the research subjects
Collaborator Contribution BK are providing the machine
Impact positive data and a patent
Start Year 2016
 
Description UCB Pharma (CiC3 hESC derived cells) 
Organisation UCB Pharma
Country United Kingdom 
Sector Private 
PI Contribution Collaboration agreement - project knowledge
Collaborator Contribution Expertise
Impact to be confirmed
Start Year 2016
 
Description Univ of Toulouse - Microfluid CIC3 
Organisation University of Toulouse
Country France 
Sector Academic/University 
PI Contribution Collaboration for 2 Masters students who participated to the project in Summer of 2016
Collaborator Contribution Collaboration for 2 Masters students who participated to the project in Summer of 2016
Impact Student work will have contributed to project success and reported in further funding and collaboration outcomes.
Start Year 2016
 
Description anti bacterials CiC 3 
Organisation Selcia
Country United Kingdom 
Sector Private 
PI Contribution we are providing biology
Collaborator Contribution selcia are providing medicinal chemistry
Impact novel compounds
Start Year 2017
 
Description cic 2014 (cryopreserved hESC) 
Organisation Asymptote
Country United Kingdom 
Sector Private 
PI Contribution stem cells
Collaborator Contribution Asymptote controlled-rate freezers for cryopreserving cells for clinical application
Impact new improved methods
Start Year 2015
 
Title "A method of, and apparatus for, determination of position in ultrasound imaging 
Description "A method of, and apparatus for, determination of position in ultrasound imaging 
IP Reference WO2017013443 
Protection Patent application published
Year Protection Granted
Licensed Commercial In Confidence
Impact significant partnership
 
Title Assay - miRNA sensors for disease diagnostics 
Description A biosensor comprising a swellable biologically sensitive element comprising a nucleic acid probe and a physicoelectrical transducer associated with the swellable biologically sensitive element. The physicoelectrical transducer converts the swelling of the swellable biologically sensitive element into a detectable electrical property. In preferred embodiments the biosensor comprises an oligonucleotide cross-linked polymer composite mounted on a suitable substrate comprising electrodes adapted to measure electrical impedance. Associated methods and devices comprising said biosensor are also provided. Patent now at PCT stage, licenced to Axis Shield 
IP Reference WO2017006122 
Protection Patent application published
Year Protection Granted
Licensed Yes
Impact novel assay system
 
Title microfluidics system 
Description microfluidic device comprising a plurality of layers and a common manifold, wherein a fluid comprising a target population of particles having a specified range of diameters may be processed by the device by flowing from the common manifold through the channels of each layer within the plurality of layers, and fluid collected from a first outlet of each layer within the plurality of layers comprises the target population of particles, and fluid collected from a second outlet of each layer within the plurality of layers is substantially devoid of the target population of particles. A method of use of said device and systems comprising at least one said device are also presented.microfluidics system 
IP Reference WO2016198880 
Protection Patent application published
Year Protection Granted
Licensed No
Impact supporting project
 
Description Explorathon 2015 - Microfluids CIC3 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach Local
Primary Audience Professional Practitioners
Results and Impact an outreach activity for introducing the notions of manufactured red blood cells from STEM cells and microfluidics for cells purification.
Year(s) Of Engagement Activity 2015
URL http://jimenezmelanie.weebly.com/news/exciting-day-at-edinburgh-zoo-for-explorathon-15
 
Description Questionnaires to Anaesthetists - Ultrasound needle CIC3 
Form Of Engagement Activity A formal working group, expert panel or dialogue
Part Of Official Scheme? No
Geographic Reach National
Primary Audience Professional Practitioners
Results and Impact Questionnaires about medical needs sent to anaesthetists at Ninewells Hospital Dundee and Edinburgh Royal Infirmary (33 responses), delegates at an Association of Anaesthetists of Great Britian and Ireland surveyed, and a further survey to another 216 anaesthetists. Market study carried out by IP Pragmatics to 611 anaesthetists.
Year(s) Of Engagement Activity 2016
 
Description SULSA prize for best video - Microfluids CIC3 
Form Of Engagement Activity Engagement focused website, blog or social media channel
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Professional Practitioners
Results and Impact Competition winner - best video about the importance of light in research
Year(s) Of Engagement Activity 2016
URL http://jimenezmelanie.weebly.com/news/winner-of-the-iop-video-competition
 
Description School visit - anti bacterials 
Form Of Engagement Activity Participation in an open day or visit at my research institution
Part Of Official Scheme? No
Geographic Reach Local
Primary Audience Schools
Results and Impact School visit to Edinburgh Protein Production Facility (Martin Wear) to inform students of work/research and encourage them to pursue career in medical research. Q&A session followed the tour.
Year(s) Of Engagement Activity 2016
 
Description Set for Britian - Microfluids CIC3 
Form Of Engagement Activity A formal working group, expert panel or dialogue
Part Of Official Scheme? No
Geographic Reach National
Primary Audience Policymakers/politicians
Results and Impact Presenting work to Parliament for SET for BRITAIN 2016-Engineering
Year(s) Of Engagement Activity 2016
URL http://jimenezmelanie.weebly.com/news/set-for-britain-2016
 
Description Study added to Join Dementia Research (AD device) 
Form Of Engagement Activity Engagement focused website, blog or social media channel
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Public/other audiences
Results and Impact Added study to Join Dementia Research (JDR) to increase recruitment to study and advertise research being carried out.
Year(s) Of Engagement Activity 2016
 
Description miRNA 
Form Of Engagement Activity Participation in an activity, workshop or similar
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Public/other audiences
Results and Impact Participated in a Edinburgh Fringe Festival Show as part of the Cabaret of Dangerous Ideas
Year(s) Of Engagement Activity 2016
 
Description microTAS 2016 - Microfuid CIC3 
Form Of Engagement Activity Participation in an activity, workshop or similar
Part Of Official Scheme? No
Geographic Reach National
Primary Audience Professional Practitioners
Results and Impact Outreach event with the lego DLD
Year(s) Of Engagement Activity 2016
URL http://www.microtas2016.org/